XHKG2160
Market cap210mUSD
Jan 03, Last price
0.68HKD
1D
3.03%
1Q
-36.45%
IPO
-96.04%
Name
Microport Cardioflow Medtech Corp
Chart & Performance
P/E
—
P/S
4.59
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
%
Revenues
336m
+33.94%
Net income
-472m
L+3.77%
CFO
-207m
L+13.40%
Earnings
Mar 25, 2025
Profile
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
IPO date
Feb 04, 2021
Employees
579
Domiciled in
CN
Incorporated in
KY
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 336,215 33.94% | 251,026 25.00% | ||||
Cost of revenue | 636,851 | 545,447 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (300,636) | (294,421) | ||||
NOPBT Margin | ||||||
Operating Taxes | 7,952 | 3,096 | ||||
Tax Rate | ||||||
NOPAT | (308,588) | (297,517) | ||||
Net income | (471,534) 3.77% | (454,395) 147.95% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 3,443 | (103,538) | ||||
BB yield | -0.09% | 1.68% | ||||
| Debt | ||||||
Debt current | 28,568 | 31,041 | ||||
Long-term debt | 112,392 | 159,895 | ||||
Deferred revenue | 6,750 | 5,890 | ||||
Other long-term liabilities | 5,890 | |||||
Net debt | (1,091,496) | (1,973,554) | ||||
| Cash flow | ||||||
Cash from operating activities | (206,985) | (182,532) | ||||
CAPEX | (27,921) | (49,072) | ||||
Cash from investing activities | (596,056) | (179,778) | ||||
Cash from financing activities | (25,609) | (136,420) | ||||
FCF | (846,894) | (263,668) | ||||
| Balance | ||||||
Cash | 1,065,085 | 1,866,319 | ||||
Long term investments | 167,371 | 298,171 | ||||
Excess cash | 1,215,645 | 2,151,939 | ||||
Stockholders' equity | (1,748,249) | (1,278,697) | ||||
Invested Capital | 4,160,342 | 4,137,887 | ||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 2,362,906 | 2,365,637 | ||||
Price | 1.62 -37.93% | 2.61 -28.30% | ||||
Market cap | 3,827,908 -38.00% | 6,174,313 -27.24% | ||||
EV | 2,736,412 | 4,332,501 | ||||
EBITDA | (227,018) | (216,206) | ||||
EV/EBITDA | ||||||
Interest | 3,915 | 5,188 | ||||
Interest/NOPBT | ||||||